Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

被引：0

作者：

Antoine Monsel

Caroline Hauw-Berlemont

Miryam Mebarki

Nicholas Heming

Julien Mayaux

Otriv Nguekap Tchoumba

Jean-Luc Diehl

Alexandre Demoule

Djillali Annane

Clémence Marois

Sophie Demeret

Emmanuel Weiss

Guillaume Voiriot

Muriel Fartoukh

Jean-Michel Constantin

Bruno Mégarbane

Gaëtan Plantefève

Stéphanie Malard-Castagnet

Sonia Burrel

Michelle Rosenzwajg

Nicolas Tchitchek

Hélène Boucher-Pillet

Guillaume Churlaud

Audrey Cras

Camille Maheux

Chloé Pezzana

Mamadou Hassimiou Diallo

Jacques Ropers

Philippe Menasché

Jérôme Larghero

机构：

[1] Assistance Publique-Hôpitaux de Paris (APHP) Sorbonne University,Multidisciplinary Intensive Care Unit, Department of Anesthesiology and Critical Care, La Pitié–Salpêtrière Hospital

[2] Sorbonne Université–INSERM UMRS_959,Biotherapy (CIC

[3] Immunology–Immunopathology–Immunotherapy (I3),BTi), Hôpital Pitié

[4] APHP,Salpêtrière

[5] Université de Paris,Intensive Care Unit, APHP

[6] Université de Paris,CUP, Hôpital Européen Georges

[7] University Versailles Saint Quentin–University Paris Saclay,Pompidou

[8] APHP,APHP, Hôpital Saint

[9] Groupe Hospitalier Universitaire–Sorbonne Université,Louis, Unité de Thérapie Cellulaire, Centre d’Investigation Clinique en Biothérapies CBT501, INSERM

[10] site Pitié–Salpêtrière,FHU SEPSIS, Department of Intensive Care, Hôpital Raymond

[11] Service de Médecine Intensive et Réanimation (Département R3S),Poincaré (APHP), Laboratory of Infection & Inflammation–INSERM U1173, Simone Veil School of Medicine

[12] and Sorbonne Université,Innovative Therapies in Hemostasis, INSERM, 75006 Paris, France, and Biosurgical Research Laboratory (Carpentier Foundation), APHP

[13] INSERM,CUP, Hôpital Européen Georges

[14] UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique,Pompidou

[15] Université de Paris,Neurological Intensive Care Unit, Department of Neurology, La Pitié–Salpêtrière Hospital, APHP

[16] Sorbonne University,Groupe de Recherche Clinique en REanimation et Soins intensifs du Patient en Insuffisance Respiratoire aiguE (GRC

[17] Sorbonne Université,RESPIRE)

[18] APHP Nord,Department of Anesthesiology and Critical Care, Beaujon Hospital, DMU PARABOL

[19] INSERM and Université de Paris,Center for Research on Inflammation

[20] Sorbonne Université,Service de Médecine Intensive Réanimation, Hôpital Tenon, APHP

[21] University of Paris,Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS1144

[22] Centre Hospitalier Victor Dupouy,Service de Réanimation Polyvalente

[23] Hôpital Saint-Louis,Immunology and HLA Laboratory

[24] Sorbonne Université,INSERM U1136, Institut Pierre

[25] APHP,Louis d’Epidémiologie et de Santé Publique (iPLESP), APHP, Hôpital Pitié–Salpêtrière, Service de Virologie

[26] Hôpital Saint-Louis,INSERM UMR1140

[27] Centre MEARY de Thérapie Cellulaire et Génique,INSERM, UMR S 970, Paris Centre de Recherche Cardiovasculaire (PARCC)

[28] Université de Paris,Clinical Research Unit, Pitié–Salpêtrière University Hospital

[29] Université de Paris,Department of Cardiovascular Surgery

[30] APHP,Multidisciplinary Intensive Care Unit, Department of Anesthesiology–Critical Care and Perioperative Medicine

[31] Hôpital Européen Georges-Pompidou,Internal Use Pharmacy Department, REQPHARM Unit, La Pitié–Salpêtrière Hospital

[32] Hôpital de la Pitié–Salpêtrière,Clinical Investigation Center (CIC) at La Pitié–Salpêtrière Hospital, Assistance Publique

[33] Assistance Publique-Hôpitaux de Paris (APHP) Sorbonne University,Hôpitaux de Paris (APHP)

[34] Sorbonne University,undefined

来源：

Critical Care | / 26卷

关键词：

Severe acute respiratory syndrome coronavirus-2; Acute respiratory distress syndrome; Umbilical cord-derived mesenchymal stromal cells; Good-manufacturing practice;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Sertraline in the treatment of panic disorder: A double-blind multicenter trial
Pohl, RB
Wolkow, RM
Clary, CM
AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (09): : 1189 - 1195
[42] Effect of Naoxinqing tablet in the treatment of convalescent stroke:a multicenter,randomized,double-blind,control trial
黄坚红
ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (04) : 201 - 202
[43] Budesonide treatment for collagenous colitis:: A randomized, double-blind, placebo-controlled, multicenter trial
Miehlke, S
Heymer, P
Bethke, B
Bästlein, E
Meier, E
Bartram, HP
Wilhelms, G
Lehn, N
Dorta, G
Delarive, J
Tromm, A
Bayerdörffer, E
Stolte, M
GASTROENTEROLOGY, 2002, 123 (04) : 978 - 984
[44] Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
Payares-Herrera, Concepcion
Martinez-Munoz, Maria E.
Vallhonrat, Ines Lipperheide
de Molina, Rosa Malo
Torres, Manuel Perez
Trisan, Andrea
de Diego, Isabel Salcedo
Alonso, Rosalia
Zafra, Rocio
Donaire, Trinidad
Sanchez, Rocio
Rubio, Juan Jose
Duarte Palomino, Rafael F.
Sola, Cristina Avendano
TRIALS, 2021, 22 (01)
[45] Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial
Concepción Payares-Herrera
María E. Martínez-Muñoz
Inés Lipperheide Vallhonrat
Rosa Malo de Molina
Manuel Pérez Torres
Andrea Trisan
Isabel Salcedo de Diego
Rosalía Alonso
Rocío Zafra
Trinidad Donaire
Rocío Sánchez
Juan José Rubio
Rafael F. Duarte Palomino
Cristina Avendaño Solá
Trials, 22
[46] Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial
Davoodi, Lotfollah
Jafarpour, Hamed
Oladi, Ziaeddin
Zakariaei, Zakaria
Tabarestani, Mohammad
Ahmadi, Bahareh Moayed
Razavi, Alireza
Hessami, Amirhossein
IJC HEART & VASCULATURE, 2021, 36
[47] Pentoxifylline effects on hospitalized patients with COVID19: A randomized, double-blind clinical trial
Azizi, Hanieh
Rouhani, Nima
Shaki, Fatemeh
Karimpour-razkenari, Elahe
Ghazaeian, Monireh
Salehifar, Ebrahim
Saeedi, Majid
Fallah, Sahar
INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
[48] A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
O'Donnell, Max R.
Grinsztejn, Beatriz
Cummings, Matthew J.
Justman, Jessica E.
Lamb, Matthew R.
Eckhardt, Christina M.
Philip, Neena M.
Cheung, Ying Kuen
Gupta, Vinay
Joao, Esau
Pilotto, Jose Henrique
Diniz, Maria Pia
Cardoso, Sandra Wagner
Abrams, Darryl
Rajagopalan, Kartik N.
Borden, Sarah E.
Wolf, Allison
Sidi, Leon Claude
Vizzoni, Alexandre
Veloso, Valdilea G.
Bitan, Zachary C.
Scotto, Dawn E.
Meyer, Benjamin J.
Jacobson, Samuel D.
Kantor, Alex
Mishra, Nischay
Chauhan, Lokendra, V
Stone, Elizabeth F.
Dei Zotti, Flavia
La Carpia, Francesca
Hudson, Krystalyn E.
Ferrara, Stephen A.
Schwartz, Joseph
Stotler, Brie A.
Lin, Wen-Hsuan W.
Wontakal, Sandeep N.
Shaz, Beth
Briese, Thomas
Hod, Eldad A.
Spitalnik, Steven L.
Eisenberger, Andrew
Lipkin, Walter, I
JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (13):
[49] Mesenchymal Stem (stromal) Cells For Treatment Of Ards:A Phase 1 Clinical Trial
Wilson, J. G.
Liu, K.
Zhuo, H.
Caballero, L.
McMillan, M.
Fang, X.
Cosgrove, K.
Vojnik, R.
Calfee, C. S.
Lee, J. -W.
Rogers, A. J.
Levitt, J. E.
Wiener-Kronish, J. P.
Bajwa, E.
Leavitt, A.
McKenna, D.
Thompson, T.
Matthay, M. A.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
[50] Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial
Ahmadi, Sedigheh
Mehrabi, Zeinab
Zare, Morteza
Ghadir, Sara
Masoumi, Seyed Jalil
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023

← 1 2 3 4 5 →